{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=70", "query": { "intervention": "Control Comparator", "page": 70 }, "page_size": 10 }, "pagination": { "page": 70, "page_size": 10, "total_count": 1671, "total_pages": 168, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=71&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=69&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T16:40:37.986Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04629664", "title": "FX-322 in Adults With Severe Sensorineural Hearing Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hearing Loss, Sensorineural", "Noise Induced Hearing Loss", "Sudden Hearing Loss" ], "interventions": [ { "name": "FX-322", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Frequency Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2020-11-02", "completion_date": "2021-09-20", "has_results": false, "last_update_posted_date": "2022-02-01", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 7, "location_summary": "Novi, Michigan • Omaha, Nebraska • Amherst, New York + 3 more", "locations": [ { "city": "Novi", "state": "Michigan" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Amherst", "state": "New York" }, { "city": "Orangeburg", "state": "South Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04629664" }, { "nct_id": "NCT07612449", "title": "Percepta for Cognitive Optimization", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mild Cognitive Impairment (MCI)", "Memory" ], "interventions": [ { "name": "Percepta", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Cerebrum DAO Association", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 154, "start_date": "2026-09-14", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 1, "location_summary": "Wilmington, Delaware", "locations": [ { "city": "Wilmington", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT07612449" }, { "nct_id": "NCT03330548", "title": "Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hyperlipidemias", "Overweight and Obesity", "Diabetes" ], "interventions": [ { "name": "TeleMOVE!", "type": "BEHAVIORAL" }, { "name": "Culinary Rx", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Phoenix VA Health Care System", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 87, "start_date": "2015-07-09", "completion_date": "2021-03-05", "has_results": false, "last_update_posted_date": "2021-03-11", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03330548" }, { "nct_id": "NCT03272347", "title": "Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "Islatravir", "type": "DRUG" }, { "name": "Placebo to Islatravir", "type": "DRUG" }, { "name": "Doravirine", "type": "DRUG" }, { "name": "Placebo to Doravirine", "type": "DRUG" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Placebo to Lamivudine", "type": "DRUG" }, { "name": "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate", "type": "DRUG" }, { "name": "Placebo to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate", "type": "DRUG" }, { "name": "Doravirine/Islatravir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 123, "start_date": "2017-11-27", "completion_date": "2022-03-09", "has_results": true, "last_update_posted_date": "2023-03-29", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03272347" }, { "nct_id": "NCT02201524", "title": "Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "PF-04965842", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 59, "start_date": "2014-11", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2016-10-05", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Rogers, Arkansas • Encinitas, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02201524" }, { "nct_id": "NCT07679035", "title": "Study of Shunt Flow Under Different Valve Settings Using a Wireless Sensor", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hydrocephalus" ], "interventions": [ { "name": "Rhaeos Shunt Monitoring System (RSMS)", "type": "DEVICE" }, { "name": "ShuntCheck III", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Rhaeos, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 85, "start_date": "2026-06-30", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07679035" }, { "nct_id": "NCT04349774", "title": "Erector Spinae Plane Block vs Erector Spinae Plane Block With Serratus Anterior Plane Block in Thoracic Surgery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Control Group - ESP block with SAP block", "type": "DRUG" }, { "name": "Treatment Group - ESP block with SAP normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anna Uskova", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2022-10-01", "completion_date": "2023-12-30", "has_results": false, "last_update_posted_date": "2022-11-14", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04349774" }, { "nct_id": "NCT06666426", "title": "This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adult Nocturnal Enuresis", "Urinary Incontinence (UI)" ], "interventions": [ { "name": "PureWick System", "type": "DEVICE" }, { "name": "Hollister Female Urinary Pouch External Collection Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "C. R. Bard", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 171, "start_date": "2024-10-31", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2025-07-24", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 15, "location_summary": "Guntersville, Alabama • Chandler, Arizona • Eagle Rock, California + 12 more", "locations": [ { "city": "Guntersville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Eagle Rock", "state": "California" }, { "city": "Greenacres City", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06666426" }, { "nct_id": "NCT05175040", "title": "PROphylactic Manual RotatIon in the Second stagE of Labor", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Labor Complication", "Pregnancy Related" ], "interventions": [ { "name": "Prophylactic manual rotation", "type": "PROCEDURE" }, { "name": "Sham rotation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 42, "start_date": "2022-03-04", "completion_date": "2023-12-15", "has_results": false, "last_update_posted_date": "2024-03-26", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05175040" }, { "nct_id": "NCT00713518", "title": "Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Age Related Macular Degeneration" ], "interventions": [ { "name": "0.5 mg ranibizumab", "type": "DRUG" }, { "name": "3 mg PF-04523655", "type": "DRUG" }, { "name": "1 mg PF-04523655", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quark Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 152, "start_date": "2009-11", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2012-10-12", "last_synced_at": "2026-10-28T16:40:37.986Z", "location_count": 7, "location_summary": "San Francisco, California • Fort Myers, Florida • Winter Haven, Florida + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Winter Haven", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00713518" } ] }